You are here


The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.

12 October 2016

Zimbabwe: Improved treatment coverage cuts TB rates

Expanding access to treatment for people living with HIV is shown to decrease tuberculosis (TB) incidence – but it is not the silver bullet.

07 October 2016

New cervical screening method could save women’s lives in low-income countries

Study in South Africa and Burkina Faso shows that simple HPV screening could help save lives in places with limited health infrastructure.

05 October 2016

Kenya leads the way in child-friendly TB treatment

Kenya becomes first country in the world to introduce child-friendly tuberculosis (TB) medicine. It is hoped that the roll-out of this medication will drastically reduce the number of child TB deaths in the country.

30 September 2016

10% of children living with HIV don’t develop AIDS because immune system ignores HIV

The natural ability of some children's immune systems to hold off attacking HIV, thus stopping diseases progression, may provide clues for future treatment.

29 September 2016

The Philippine drug war: a crisis of human rights and HIV

3,000 people have been killed in drug-related crackdowns. This hard-line stance threatens to derail the HIV response in the country, as harm reduction services face mounting pressure to close.

26 September 2016

Prisoners in Zambia need better access to HIV services

Zambian officials promote absitinence in prisons, turning a blind eye to the HIV prevention needs of men who have sex with men

20 September 2016

African nations, private donors and high-income countries rally together to raise $US 13 billion for the Global Fund

Nearly US$ 13 billion has been pledged to the Global Fund to Fight AIDS, Tuberculosis and Malaria, to accelerate the response to end these diseases over the next three years.

14 September 2016

Europe grants marketing approval of Truvada for use as PrEP

The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.

13 September 2016

Kenya to scale-up access to PrEP for adolescent girls and young women

The Gates Foundation awards grant to expand access to pre-exposure prophylaxis (PrEP) for key populations in Kenya.